Effects of interacting networks of cardiovascular risk genes on the risk of type 2 diabetes mellitus (the CODAM study)

Marleen MJ van Greevenbroek , Jian Zhang , Carla JH van der Kallen , Paul MH Schiffers , Edith JM Feskens and Tjerk WA de Bruin

BMC Medical Genetics 2008, 9:36doi:10.1186/1471-2350-9-36


Published:	24 April 2008

Abstract (provisional)

Background

Genetic dissection of complex diseases requires innovative approaches for identification of disease-predisposing genes. A well-known example of a human complex disease with a strong genetic component is Type 2 Diabetes Mellitus (T2DM).

Methods

We genotyped normal-glucose-tolerant subjects (NGT; n=54), subjects with an impaired glucose metabolism (IGM; n=111) and T2DM (n=142) subjects, in an assay (designed by Roche Molecular Systems) for detection of 68 polymorphisms in 36 cardiovascular risk genes. Using the single-locus logistic regression and the so-called haplotype entropy, we explored the possibility that (1) common pathways underlie development of T2DM and cardiovascular disease -which would imply enrichment of cardiovascular risk polymorphisms in pre-diabetic (IGM) and diabetic (T2DM) populations- and (2) that gene-gene interactions are relevant for the effects of risk polymorphisms.

Results

In single-locus analyses, we showed suggestive association with disturbed glucose metabolism (IGM or T2DM), or with T2DM only. Moreover, in the haplotype entropy analysis, we identified a total of 14 pairs of polymorphisms (with a false discovery rate of 0.125) that may confer risk of IGM or T2DM, or T2DM only, as members of interacting networks of genes. We substantiated gene-gene interactions by showing that these interacting networks can indeed identify potential disease-predisposing allele-combinations.

Conclusion

Gene-gene interactions of cardiovascular risk polymorphisms can be detected in prediabetes and T2DM, supporting the hypothesis that common pathways may underlie development of T2DM and cardiovascular disease. Thus, a specific set of risk polymorphisms, when simultaneously present, increases the risk of disease and hence is indeed relevant in the transfer of risk.